Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
Salim Syed Maintained (UBX) at Strong Buy with Increased Target to $80 on, Aug 16th, 2022
Salim Syed of Mizuho, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Increased Target from $70 to $80 on, Aug 16th, 2022.
Salim has made no other calls on UBX in the last 4 months.
There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Salim's Rating of Hold.
This is the rating of the analyst that currently disagrees with Salim
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $80 on, Monday, August 15th, 2022
